Haemonetics (HAE) EPS (Basic) (2009 - 2026)

Haemonetics' EPS (Basic) history runs 18 years deep, the most recent figure standing at -$0.41 for Q1 2026.

• In Q1 2026, EPS (Basic) fell 135.04% year-over-year to -$0.41; the TTM figure through Mar 2026 stood at $2.07 (down 37.84% YoY), while the FY2026 annual figure was $2.06, down 38.14% from the prior year.
• EPS (Basic) was -$0.41 for Q1 2026 at Haemonetics, down from $0.96 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $1.17 in Q1 2025 to a low of -$0.41 in Q1 2026.
• Historically, EPS (Basic) has averaged $0.59 across 5 years, with a median of $0.65 in 2022.
• The sharpest annual moves came in 2022 and 2026: EPS (Basic) jumped 533.33% in 2022, then plunged 135.04% in 2026.
• A 5-year view of EPS (Basic) shows it stood at $0.65 in 2022, then fell by 4.62% to $0.62 in 2023, then rose by 20.97% to $0.75 in 2024, then grew by 28.0% to $0.96 in 2025, then tumbled by 142.71% to -$0.41 in 2026.
• The last three EPS (Basic) figures came in at -$0.41 (Q1 2026), $0.96 (Q4 2025), and $0.81 (Q3 2025), per Business Quant data.